Pharmacokinetic Comparability
Pharmacokinetic Comparability is a scientific criterion used in generic drug evaluation to establish that the rate and extent of absorption of an active ingredient from a test product are not significantly different from those of a reference product under similar experimental conditions.
112
Publications
3.5K
Citations
551
Authors
206
Institutions
Publications per year
2017–2026
13
Parents
112
Inter‐subject and ethnic differences in paracetamol metabolism.
G. R. Nimmo, CA Gregson, NM Woolhouse et al. · British Journal of Clinical Pharmacology · 1986 · 138 citations · Full text
Ichiro Ieiri, Yohei Doi, Kazuya Maeda et al. · The Journal of Clinical Pharmacology · 2011 · 106 citations
1–5 of 112
551
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 551
206
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
3 h-index
14 publications
565 citations
Novartis (Switzerland)
Basel, Switzerland
3 h-index
6 publications
138 citations
Medicines Evaluation Board
Utrecht, Netherlands
3 h-index
10 publications
260 citations
Pfizer (United States)
New York, United States
2 h-index
2 publications
26 citations

Radboud University Medical Center
Nijmegen, The Netherlands
2 h-index
3 publications
64 citations
Takeda (United States)
Deerfield, United States
2 h-index
4 publications
51 citations
Bristol-Myers Squibb (United States)
New York, United States
2 h-index
2 publications
50 citations
University of Wisconsin–Madison
Madison, United States
2 h-index
10 publications
175 citations
1–8 of 206
Repository · 14 publications · 366 citations
11
h-index
6 publications · 351 citations
6
h-index
6 publications · 96 citations
6
h-index
CPT · 5 publications · 160 citations
5
h-index
BJCP · 4 publications · 237 citations
4
h-index
1–5